Takamiya Y, Okamura K, Shirai K, Okuda T, et al. Multicenter prospective observational study of teneligliptin, a selective dipeptidyl peptidase-4 inhibitor, in patients with poorly controlled type 2 diabetes: Focus on glycemic control, hypotensive effect, and safety Chikushi Anti-Diabetes Mellitus T Clin Exp Hypertens 2020;42:197-204.
PMID: 30974980